Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Gene mutations in Cushing's disease.

Xiong Q, Ge W.

Biomed Rep. 2016 Sep;5(3):277-282.

2.

cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.

Bolger GB, Bizzi MF, Pinheiro SV, Trivellin G, Smoot L, Accavitti MA, Korbonits M, Ribeiro-Oliveira A Jr.

Endocr Relat Cancer. 2016 May;23(5):419-31. doi: 10.1530/ERC-15-0205.

PMID:
27267386
3.

Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations.

Hernández-Ramírez LC, Martucci F, Morgan RM, Trivellin G, Tilley D, Ramos-Guajardo N, Iacovazzo D, D'Acquisto F, Prodromou C, Korbonits M.

J Clin Endocrinol Metab. 2016 Aug;101(8):3144-54. doi: 10.1210/jc.2016-1307.

4.

Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.

Iacovazzo D, Caswell R, Bunce B, Jose S, Yuan B, Hernández-Ramírez LC, Kapur S, Caimari F, Evanson J, Ferraù F, Dang MN, Gabrovska P, Larkin SJ, Ansorge O, Rodd C, Vance ML, Ramírez-Renteria C, Mercado M, Goldstone AP, Buchfelder M, Burren CP, Gurlek A, Dutta P, Choong CS, Cheetham T, Trivellin G, Stratakis CA, Lopes MB, Grossman AB, Trouillas J, Lupski JR, Ellard S, Sampson JR, Roncaroli F, Korbonits M.

Acta Neuropathol Commun. 2016 Jun 1;4(1):56. doi: 10.1186/s40478-016-0328-1.

5.

Multiple Pituitary Adenomas: A Systematic Review.

Budan RM, Georgescu CE.

Front Endocrinol (Lausanne). 2016 Feb 1;7:1. doi: 10.3389/fendo.2016.00001. Review.

6.

Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.

Hernández-Ramírez LC, Gabrovska P, Dénes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M; International FIPA Consortium..

J Clin Endocrinol Metab. 2015 Sep;100(9):E1242-54.

7.
8.

Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.

Zhou Q, Lavorgna A, Bowman M, Hiscott J, Harhaj EW.

J Biol Chem. 2015 Jun 5;290(23):14729-39. doi: 10.1074/jbc.M114.633065.

9.

Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.

Dénes J, Kasuki L, Trivellin G, Colli LM, Takiya CM, Stiles CE, Barry S, de Castro M, Gadelha MR, Korbonits M.

PLoS One. 2015 Feb 6;10(2):e0117107. doi: 10.1371/journal.pone.0117107.

10.

The role of genetic and epigenetic changes in pituitary tumorigenesis.

Fukuoka H, Takahashi Y.

Neurol Med Chir (Tokyo). 2014;54(12):943-57. Review.

11.

Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.

Zhou Y, Zhang X, Klibanski A.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):16-33. doi: 10.1016/j.mce.2013.09.006. Review.

12.
13.

Structure of the TPR domain of AIP: lack of client protein interaction with the C-terminal α-7 helix of the TPR domain of AIP is sufficient for pituitary adenoma predisposition.

Morgan RM, Hernández-Ramírez LC, Trivellin G, Zhou L, Roe SM, Korbonits M, Prodromou C.

PLoS One. 2012;7(12):e53339. doi: 10.1371/journal.pone.0053339.

14.

Clinical and genetic aspects of familial isolated pituitary adenomas.

Vasilev V, Daly A, Naves L, Zacharieva S, Beckers A.

Clinics (Sao Paulo). 2012;67 Suppl 1:37-41. Review.

15.

The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α.

Cai W, Kramarova TV, Berg P, Korbonits M, Pongratz I.

PLoS One. 2011;6(10):e25201. doi: 10.1371/journal.pone.0025201.

16.

Familial pediatric endocrine tumors.

Millar S, Bradley L, Donnelly DE, Carson D, Morrison PJ.

Oncologist. 2011;16(10):1388-96. doi: 10.1634/theoncologist.2011-0120. Review.

Items per page

Supplemental Content

Support Center